Study of medicines’ market for the treatment of seborrheic dermatitis of the pilar part of head
Aktualʹnì Pitannâ Farmacevtičnoï ì Medičnoï Nauki ta Praktiki, 2018 Modern arsenal of medicines and cosmetics used for the therapy of seborrheic dermatitis of the pilar part of head is various enough. Today pharmaceutical market keeps developing and constitutes a complex system that causes the necessity of its ...
V. A. Solodovnik +3 more
doaj +1 more source
Cost-benefit analysis of pharmacist interventions over 36 months in a university hospital
Revista de Saúde Pública, 2020 OBJECTIVE: To perform a cost-benefits analysis of a clinical pharmacy (CP) service implemented in a Neurology ward of a tertiary teaching hospital. METHODS: This is a cost-benefit analysis of a single arm, prospective cohort study performed at the adult
Maurilio de Souza Cazarim +4 more
doaj +1 more source
Pharmaceutical and Biomedical Research, 2021 Background: Irrational use of drugs is a serious global problem, especially in developing countries. Scientific evidence has announced albumin and intravenous pantoprazole as expensive drugs, i.e., relatively irrationally applied in hospitals without ...
Nader Sharifi +4 more
doaj
Development of Holistic integrative pharmacy Based on Clinical Pharmacy
Journal of Holistic Integrative Pharmacy, 2020 [Abstract]: With advances in modern medicine, life science technologies, economics, information technologies, and the Internet, the focus of clinical pharmacy is transitioning from drug product-oriented to patient-oriented.
Xin ZHAO, Xiong LI
doaj +1 more source
Can’t Buy Me Rights! The Contractual Structure of Asymmetrical Inter-firm Collaborations [PDF]
, 2006 The efficient allocation of control rights in inter-firm collaborations is a widely emphasized issue. In this paper, I empirically identify control rights and the allocation of these rights using a unique survey data set on collaborations between ...
Häussler, Carolin
core +2 more sources
SIMULATION TECHNOLOGIES IN THE MODELLING USERS’ BEHAVIORS IN THE PHARMACEUTICAL MARKET
Вісник Харківського національного університету імені В.Н. Каразіна: Серія Економіка, 2019 The creation of a new branch of economics – behavioural economics studying the features of decision-making, resulted in changes of a number of fundamental ideas.
Zoia Sokolovska, Irina Kapustya
doaj +1 more source
Pharmacoeconomic analysis of antineoplastics at the Oncology Institute of Vojvodina from 2005 to 2008 [PDF]
Archive of Oncology, 2009 Contemporary cancer chemotherapy need to be active against malignant cell (selectivity), to be based on the molecular biology of the cancer cell, to enhance immune response to cancer, and to stop development of resistance to drug.
Ilić Maja S.
doaj +1 more source
High growth firms, innovation and competition: the case of the US pharmaceutical industry [PDF]
, 2013 Innovation is key to economic growth. But firms, across sectors and regions, are highly skewed in their ability to engage with innovation, and even more skewed in their ability to translate investments in innovation into higher growth.
Mazzucato, Mariana, Parris, Stuart
core +2 more sources
ECONOMIC ENVIRONMENT THE ACTIVITIES OF PHARMACEUTICAL ORGANIZATIONS
Вестник Северо-Кавказского федерального университета, 2022 Pharmaceutical business in modern conditions is for entrepreneurs and investors a very attractive and promising area of activity that requires further comprehensive research in the field of Economics and management.
E. Manvelyan, R. Petinov, M. Manvelyan
doaj
Valuation implications of pharmaceutical companies' R&D regulatory approval notifications [PDF]
, 2013 This paper examines shareholder wealth effects surrounding applications to, and approvals by, the United States Food and Drug Administration (FDA) for firms listed on the New York (NYSE) and London (LSE) stock exchanges.
Hamill, P.A., McIlkenny, P., Opong, K.K.
core +1 more source